Search results (522)
« Back to PublicationsGuideline clarification: dropout in FDA-cleared dCBT-I is comparable to pharmacotherapy and therapist-delivered CBT-I.
Journal article
Henry AL. et al, (2026), J Clin Sleep Med, 22
Sleep and circadian health in the UK Biobank: report on the 2023 sleep questionnaire enhancement
Journal article
Tse KYK. et al, (2026), SLEEP, 49
Association of Prodromal Parkinson's Disease-Like Features in Long COVID With Dream-Enactment Behaviours.
Journal article
Gong S. et al, (2026), J Sleep Res
Insights from nine nights of self-applied, low-density sleep EEG during sleep restriction therapy: a proof-of-concept evaluation
Preprint
Stanyer EC. et al, (2026)
Lucid Dreaming: Not Just Awareness, but Agency.
Journal article
Ableidinger S. et al, (2026), J Sleep Res, 35
Corrigendum to "Long COVID as a risk factor for hypersomnolence and fatigue: insights from the 2nd International Covid Sleep Study Collaboration (ICOSS-2)" [Sleep Med. 136 (2025) 106764].
Journal article
Sarkanen T. et al, (2026), Sleep Med, 140
The DREAMS START intervention for sleep in dementia: Long‐term follow‐up of a randomized controlled trial
Journal article
Rapaport P. et al, (2026), Alzheimer's & Dementia, 22
Sleep Improvement for Metabolic Health: A Feasibility Trial of a Digital Sleep Treatment in People With Insomnia and Non‐Diabetic Hyperglycaemia
Journal article
Sharman R. et al, (2026), Journal of Sleep Research
The clinical and cost-effectiveness of improving sleep via carer delivered strategies in people with dementia: the DREAMS START parallel multi-centre RCT
Journal article
Rapaport P. et al, (2026), Health Technology Assessment, 1 - 26
Letter to the editor: Higher risk evidence underlying claims of therapist-delivered CBT-I superiority
Journal article
Miller CB. et al, (2026), Sleep Medicine Reviews, 85, 102234 - 102234
Prevalence Rates of Frequent Dream Recall and Nightmares by Age, Gender and Sleep Duration in 16 Countries.
Journal article
Bolstad CJ. et al, (2026), J Sleep Res, 35
The Effectiveness of Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial.
Journal article
Prather AA. et al, (2025), JMIR Ment Health, 12
Long COVID as a risk factor for hypersomnolence and fatigue: insights from the 2nd International Covid Sleep Study Collaboration (ICOSS-2).
Journal article
Sarkanen T. et al, (2025), Sleep Med, 136
Development of a core outcome set for clinical trials of interventions to improve sleep in people with cognitive impairment-the Sleep in Cognitive Impairment Core Outcome Set (SCICOS).
Journal article
Crowley P. et al, (2025), Alzheimers Dement, 21
PRO: CBT-I for insomnia treatment can be delivered by a range of healthcare providers.
Journal article
Espie CA. et al, (2025), Sleep, 48